Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.

Literature DB >> 15215130

Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.

Abstract

Lysostaphin is an endopeptidase that kills Staphylococcus aureus, a predominant organism in catheter-related infections. Lysostaphin-coated catheters prevented catheter colonization by several strains of S. aureus, and activity was maintained for at least 4 days. Prophylactic use of lysostaphin in catheters may help prevent the occurrence of catheter-related staphylococcal infections.

Entities: Disease Species

Mesh：

Substances：

Year: 2004 PMID： 15215130 PMCID： PMC434171 DOI： 10.1128/AAC.48.7.2704-2707.2004

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

17 in total

1. Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus.

Authors: K E Quickel; R Selden; J R Caldwell; N F Nora; W Schaffner
Journal: Appl Microbiol Date: 1971-09

Review 2. Lysostaphin: model for a specific enzymatic approach to infectious disease.

Authors: W A Zygmunt; P A Tavormina
Journal: Prog Drug Res Date: 1972

3. The selective activity of lysostaphin in vivo.

Authors: R R Martin; A White
Journal: J Lab Clin Med Date: 1967-07

4. Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits.

Authors: Issam Raad; Ray Hachem; Robert K Tcholakian; Robert Sherertz
Journal: Antimicrob Agents Chemother Date: 2002-02 Impact factor: 5.191

Review 5. Prevention of catheter related infections in patients on CAPD.

Authors: E Thodis; P Passadakis; V Vargemezis; D G Oreopoulos
Journal: Int J Artif Organs Date: 2001-10 Impact factor: 1.595

6. Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis.

Authors: Nandini Kiri; Gordon Archer; Michael W Climo
Journal: Antimicrob Agents Chemother Date: 2002-06 Impact factor: 5.191

7. Efficacy of dicloxacillin-coated polyurethane catheters in preventing subcutaneous Staphylococcus aureus infection in mice.

Authors: R J Sherertz; D M Forman; D D Solomon
Journal: Antimicrob Agents Chemother Date: 1989-08 Impact factor: 5.191

8. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors: Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal: MMWR Recomm Rep Date: 2002-08-09

9. Systemic lysostaphin in man--apparent antimicrobial activity in a neutropenic patient.

Authors: F R Stark; C Thornsvard; E P Flannery; M S Artenstein
Journal: N Engl J Med Date: 1974-08-01 Impact factor: 91.245

10. Lysostaphin: an enzymatic approach to staphylococcal disease. I. In vitro studies.

Authors: W Schaffner; M A Melly; J H Hash; M G Koenig
Journal: Yale J Biol Med Date: 1967-02

15 in total

1. Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium.

Authors: Huanli Liu; Yuan Gao; Li-Rong Yu; Richard C Jones; Christopher A Elkins; Mark E Hart
Journal: Appl Environ Microbiol Date: 2011-10-07 Impact factor: 4.792

2. Evaluation of the antimicrobial activity of lysostaphin-coated hernia repair meshes.

Authors: Rohan Satishkumar; Sriram Sankar; Yuliya Yurko; Amy Lincourt; John Shipp; B Todd Heniford; Alexey Vertegel
Journal: Antimicrob Agents Chemother Date: 2011-06-27 Impact factor: 5.191

Review 3. Antibiofilm agents: A new perspective for antimicrobial strategy.

Authors: Xi-Hui Li; Joon-Hee Lee
Journal: J Microbiol Date: 2017-09-28 Impact factor: 3.422

4. Self-cleaved expression of recombinant lysostaphin from its cellulose binding domain fusion.

Authors: Kuan-Jung Chen; Cheng-Kang Lee
Journal: Appl Microbiol Biotechnol Date: 2022-07-06 Impact factor: 5.560

5. Anti-staphylococcal activities of lysostaphin and LytM catalytic domain.

Authors: Izabela Sabala; Ing-Marie Jonsson; Andrej Tarkowski; Matthias Bochtler
Journal: BMC Microbiol Date: 2012-06-06 Impact factor: 3.605

6. In vitro evaluation of anti-pathogenic surface coating nanofluid, obtained by combining Fe3O4/C12 nanostructures and 2-((4-ethylphenoxy)methyl)-N-(substituted-phenylcarbamothioyl)-benzamides.

Authors: Ion Anghel; Carmen Limban; Alexandru Mihai Grumezescu; Alina Georgiana Anghel; Coralia Bleotu; Mariana Carmen Chifiriuc
Journal: Nanoscale Res Lett Date: 2012-09-19 Impact factor: 4.703